Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 3, 2007, Pages 393-400

  Shen, H ^a   Agarwal, D ^a   Qi, R ^a   Chalasani, N ^a   Liangpunsakul, S ^a   Lumeng, L ^a   Yoo, H ^a   Kwo, P ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN;

CHEMOEMBOLIZATION; CONFIDENCE INTERVAL; DEMOGRAPHY; HUMAN; IMAGING; INFORMATION PROCESSING; INTERNATIONAL NORMALIZED RATIO; LIVER CANCER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SURVIVAL; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34447307982     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03395.x     Document Type: Review

References (22)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999 340 : 745 50.
2. El-serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004 127 : s27 34.
3. Llovet JM, Bruix J. Systemic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003 37 : 429 42.
4. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004 127 : s179 88.
5. Lin DY, Liaw YF, Lee TY, et al. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma- a randomized controlled trial. Gastroenterology 1988 94 : 453 6.
6. Pelletier G, Roche A, Ink O, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990 11 : 181 4.
7. Group d'Etude et de Traitment du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995 332 : 1256 61.
8. Bruix J, Llovet JM, Castells A, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998 27 : 1578 83.
9. Pelletier G, Ducreux M, Gay F, et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. J Hepatol 1998 29 : 129 34.
10. Llovet JM, Real MI, Montana X, et al. Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002 359 : 1734 9.
11. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002 35 : 1164 71.
12. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL Conference. J Hepatol 2001 35 : 421 30.
13. Mazzaferro V, Regalia E, Dogi R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patient with cirrhosis. N Engl J Med 1996 334 : 693 9.
14. Mondazzi L, Bottelli R, Brambilla G, et al. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 1994 19 : 1115 23.
15. Hatanaka Y, Yamashita Y, Takahashi M, et al. Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology 1995 195 : 747 52.
16. Huang YH, Chen CH, Chang TT, et al. The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicenter study evaluated by cancer stage. Aliment Pharmacol Ther 2005 21 : 687 94.
17. Takayasu K, Arii S, Ikal I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006 131 : 461 9.
18. Tanaka K, Nakamura S, Numata K, et al. The long term efficacyof combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998 82 : 78 85.
19. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end stage liver disease. Hepatology 2001 33 : 464 70.
20. The Cancer of The Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000 31 : 840 5.
21. Levy I, Sherman M. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002 50 : 881 5.
22. Ueno S, Tanabe G, Sako K, et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Hepatology 2001 34 : 529 34.